Based on the conclusions of the study, COX-2 and 5-LOX enzymes are important targets in the development of drugs that would be used in the treatment of colorectal cancer, which has been linked to more than 600,000 deaths a year, and this incidence rate is rising in most developing countries. This evidence concerns the gene ALOX5 and colorectal cancer.